Cargando…
Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system
Autores principales: | Farsalinos, Konstantinos, Niaura, Raymond, Le Houezec, Jacques, Barbouni, Anastasia, Tsatsakis, Aristidis, Kouretas, Dimitrios, Vantarakis, Apostolos, Poulas, Konstantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192087/ https://www.ncbi.nlm.nih.gov/pubmed/32355638 http://dx.doi.org/10.1016/j.toxrep.2020.04.012 |
Ejemplares similares
-
Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions
por: Alexandris, Nikolaos, et al.
Publicado: (2020) -
COVID-19 and the nicotinic cholinergic system
por: Farsalinos, Konstantinos, et al.
Publicado: (2020) -
Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?
por: Farsalinos, Konstantinos, et al.
Publicado: (2020) -
Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Reply
por: Farsalinos, Konstantinos, et al.
Publicado: (2020) -
Nicotinic cholinergic system and COVID-19: In silico identification of interactions between α7 nicotinic acetylcholine receptor and the cryptic epitopes of SARS-Co-V and SARS-CoV-2 Spike glycoproteins
por: Lagoumintzis, George, et al.
Publicado: (2021)